Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Fillit

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Harnessing combination therapy: Current treatments, recent advancements, and future directions in Alzheimer's diseaseHoward M Fillit, Jacques Touchon, Bruno Vellas, et al.
Journal of the American Geriatrics Society|June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After DiagnosisPei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Health Affairs (Project Hope)|April 9, 2014
Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's diseasePei-Jung Lin, Zhou Yang, Howard M Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 9, 2017
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's diseasePei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2011
An analysis of global research funding for the frontotemporal dementias: 1998-2008Christopher D Walentas, Diana W Shineman, Antony R Horton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 10, 2012
Clinical trials: new opportunitiesSandra Bond Chapman, Carl W Cotman, Howard M Fillit, et al.
Alzheimer'S Research & Therapy|October 3, 2013
Progress in novel cognitive enhancers for cognitive aging and Alzheimer's diseaseDiana W Shineman, Aaron J Carman, Penny A Dacks, et al.
JMIR Aging|July 30, 2020
Artificial Intelligence-Powered Digital Health Platform and Wearable Devices Improve Outcomes for Older Adults in Assisted Living Communities: Pilot Intervention StudyGerald Wilmink, Katherine Dupey, Schon Alkire, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Beyond amyloid: the future of therapeutics for Alzheimer's diseaseRachel F Lane, Diana W Shineman, John W Steele, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trialsSamuel P Dickson, Craig Mallinckrodt, Aaron H Burstein, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Harnessing combination therapy: Current treatments, recent advancements, and future directions in Alzheimer's diseaseHoward M Fillit, Jacques Touchon, Bruno Vellas, et al.
Journal of the American Geriatrics Society|June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After DiagnosisPei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Health Affairs (Project Hope)|April 9, 2014
Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's diseasePei-Jung Lin, Zhou Yang, Howard M Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 9, 2017
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's diseasePei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2011
An analysis of global research funding for the frontotemporal dementias: 1998-2008Christopher D Walentas, Diana W Shineman, Antony R Horton, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 10, 2012
Clinical trials: new opportunitiesSandra Bond Chapman, Carl W Cotman, Howard M Fillit, et al.
Alzheimer'S Research & Therapy|October 3, 2013
Progress in novel cognitive enhancers for cognitive aging and Alzheimer's diseaseDiana W Shineman, Aaron J Carman, Penny A Dacks, et al.
JMIR Aging|July 30, 2020
Artificial Intelligence-Powered Digital Health Platform and Wearable Devices Improve Outcomes for Older Adults in Assisted Living Communities: Pilot Intervention StudyGerald Wilmink, Katherine Dupey, Schon Alkire, et al.
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Beyond amyloid: the future of therapeutics for Alzheimer's diseaseRachel F Lane, Diana W Shineman, John W Steele, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trialsSamuel P Dickson, Craig Mallinckrodt, Aaron H Burstein, et al.
Pageof 6